By John Halamka, MD
Twitter: @jhalamka
In our latest book, Reinventing Clinical Decision Support: Data Analytics, Artificial Intelligence, and Diagnostic Reasoning, Paul Cerrato and I explore the promise of artificial intelligence and machine learning for improving clinicians’ ability to make more informed diagnostic and therapeutic decisions. Here’s an excerpt from Chapter 2:
“AI is a once-in-a-generation transformative technology. As such, expect its impact to be on the scale of the advent of electricity or the Internet,” says Jean-Claude Saghbini, Wolters Kluwer Health.(1)
“Artificial intelligence and machine learning are set to transform healthcare. From front line care delivery, including triage, clinical decision support and patient experience to back office operations, such as billing and revenue cycle, algorithms and emerging technologies are already proving their value,” according to a recent report from Healthcare Information Management Services Society (HIMSS). (1)
Both enthusiastic visions suggest that artificial intelligence (AI) and machine learning (ML) are poised to transform medicine and bring in an era of cost effective patient care. But these predictions have to be weighed against less optimistic views, including those that suggest AI will disrupt the workforce in healthcare and other industries, causing many to lose their jobs to soulless algorithms and robots.
Israeli historian Yuval Noah Harari, for example, believes that: “For now, most of the skills that demand a combination between the cognitive and manual are beyond AI’s reach. Take medicine . . . ; if you compare a doctor with a nurse, it’s easier for AI to replace a doctor—who basically just analyzes data for diagnoses and suggests treatments. But replacing a nurse, who injects medications and bandages, is far more difficult. But this will change; we are really at the beginning of AI’s full potential.” (2)
There are futurists who are far more optimistic, however. They imagine a scenario in which every patient gets the same quality of care afforded presidents in affluent countries or billionaire CEOs at major technology companies. With the assistance of AI, machine learning, and massive databases, they envision a world in which we each have the electronic equivalent of a personal physician who has access to the very latest research, the best medical facilities that specialize in each individual’s health problems, access to cutting-edge data sets, predictive analytics, testing options, clinical trials currently enrolling new patients, and much more. For example, Alvin Rajkomar, MD; Jeffrey Dean, MD, of Google; and Isaac Kohane, MD, PhD, of Harvard Medical School, describe a possible future in which:
A 49-year-old patient takes a picture of a rash on his shoulder with a smartphone app that recommends an immediate appointment with a dermatologist. His insurance company automatically approves the direct referral, and the app schedules an appointment with an experienced nearby dermatologist in 2 days. This appointment is automatically cross-checked with the patient’s personal calendar. The dermatologist performs a biopsy of the lesion, and a pathologist reviews the computer-assisted diagnosis of stage I melanoma, which is then excised by the dermatologist.(3)
This scenario stands in stark contrast to the current state of affairs that often transpires in today’s broken healthcare ecosystem. As Rajkomar et al.3 point out, in today’s ecosystem, this patient is more likely to ignore his skin lesion for far too long; his primary care physician may misdiagnose the melanoma because of its atypical appearance, and the delay may result in a metastatic malignancy that requires systemic chemotherapy.
With such contrasting views, clinicians have to wonder: What precisely will the future look like? Our purpose in Chapter 2 is to explore the strengths and weaknesses of AI and ML and to help clinicians and technologists gain a realistic view of the near future—a future that promises to deliver more cost effective, more personalized care but also one that faces numerous challenges. We will explore basic terminology and concepts and discuss AI/Ml solutions in a variety of medical specialties. In Chapter 3, we will outline the many challenges that stand in the way of the full implementation of these solutions.
More details from Chapter 2 will appear in a subsequent blog. A full discussion of AI/ML is available in our book.
For cited references in this article, see original source. John D. Halamka, MD, MS, is President of the Mayo Clinic Platform, where he leads a portfolio of new digital platform businesses focused on transforming health by leveraging artificial intelligence, the internet of things, and an ecosystem of partners for Mayo Clinic. This article was originally published in his blog Dispatch from the Digital Health Frontier and is reprinted here with permission.